Clinical Trials

At BioVie, our commitment to advancing healthcare through scientific innovation is demonstrated daily through our robust research and development initiatives. Central to this are our clinical trials – crucial, scientifically rigorous testing process designed to evaluate the safety, effectiveness, and optimal usage of new medical interventions.

Clinical trials are meticulously structured studies, involving human volunteers, that stand as the gold standard for determining the potential benefits and risks of novel drugs, devices, and treatments. Guided by stringent ethical standards and regulatory oversight, these trials are the foundation upon which new solutions are brought to patients around the world, ensuring they are both safe and effective.

Logo

SUNRISE-PD (NE3107-PD-202)

A randomized, placebo-controlled Phase 2 study of bezisterim’s effect on movement symptoms in early Parkinson’s patients that have not yet been prescribed levodopa or other dopamine receptor agonists.

Learn more

ADDRESS-LC (NE3107-LC-201)

A randomized, placebo-controlled Phase 2 study to test whether bezisterim can improve brain fog and fatigue in individuals with long COVID.

Coming soon

Through innovation, collaboration, and people-driven science, BioVie is creating new solutions enabling people to live healthier and better lives.

LEARN MORE Arrow pointing to the right